Lipocine Inc. (LPCN) News Nov 20, 2014, 4:02 p.m.
Post# of 250601
Posted On: 11/20/2014 10:55:01 PM
Lipocine Inc. (LPCN) News Nov 20, 2014, 4:02 p.m.
MarketWatch News on LPCN
Bed Bath & Beyond surges on earnings 4:40 p.m. Sept. 23, 2014 - MarketWatch
Other News on LPCN
10-Q: LIPOCINE INC. 8:04 a.m. Nov. 10, 2014 - Edgar Online - (EDG = 10Q, 10K)
3 Pharmaceutical Stocks to Sell Now 2:45 a.m. Oct. 24, 2014 - InvestorPlace.com
Lipocine TRT candidate successful in feasibility trial 7:03 a.m. Oct. 13, 2014 - Seeking Alpha
3 Stocks Pushing The Conglomerates Sector Lower 3:33 p.m. Sept. 25, 2014 - TheStreet.com
LPCN 1021 hits primary endpoint in Phase 3 trial 9:52 a.m. Sept. 24, 2014 - Seeking Alpha
Why Lipocine (LPCN) Stock Is Surging in Morning Trading Today 8:50 a.m. Sept. 24, 2014 - TheStreet.com
FDA Advisory Committee Comments Create Buying Opportunity In Lipocine 10:39 a.m. Sept. 23, 2014 - Seeking Alpha
Rextoro gets thumbs down from Ad Comm 12:31 p.m. Sept. 18, 2014 - Seeking Alpha
Lipocine trading halted pending news 12:04 p.m. Sept. 17, 2014 - Seeking Alpha
Preview: FDA September 17 Adcom On Testosterone Replacement Therapy 7:42 a.m. Sept. 9, 2014 - Seeking Alpha
Lipocine Is A Compelling Investment Opportunity With Impending Phase 3 Data 9:20 a.m. Aug. 19, 2014 - Seeking Alpha
10-Q: LIPOCINE INC. 3:03 p.m. Aug. 13, 2014 - Edgar Online - (EDG = 10Q, 10K)
Lipocine: An Undervalued Biotech With An Approaching Catalyst 8:16 a.m. Aug. 13, 2014 - Seeking Alpha
5 Stocks With Ugly Sales Growth — HTS MITT UEC LPCN MNKD 5:00 a.m. Aug. 4, 2014 - InvestorPlace.com
Lipocine Inc. (LPCN) Surges: Stock Moves 11.6% Higher - Tale of the Tape 8:11 a.m. July 29, 2014 - Zacks.com
5 Stocks With Crummy Sales Growth — HTS MITT UEC LPCN MNKD 3:15 a.m. July 28, 2014 - InvestorPlace.com
5 Stocks With Bad Sales Growth — HTS MITT UEC LPCN MNKD 3:15 a.m. July 21, 2014 - InvestorPlace.com
5 Stocks With Poor Sales Growth — HTS MITT UEC LPCN MNKD 4:30 a.m. July 14, 2014 - InvestorPlace.com
5 Stocks With Crummy Sales Growth — HTS MITT UEC LPCN MNKD 3:15 a.m. July 7, 2014 - InvestorPlace.com
5 Stocks With Ugly Sales Growth — HTS MITT UEC LPCN MNKD 3:00 a.m. June 30, 2014 - InvestorPlace.com
Press Releases on LPCN
Lipocine Announces Management Changes 8:02 a.m. Nov. 17, 2014 - GlobeNewswire
Lipocine Announces Financial and Operational Results for the Third Quarter of 2014 8:01 a.m. Nov. 10, 2014 - GlobeNewswire
Lipocine Announces Positive Top-Line Results in Phase 2a Study of LPCN 1111 6:01 a.m. Oct. 13, 2014 - GlobeNewswire
IPOs and Transactions Week in Review: September 29 - October 3 1:25 p.m. Oct. 6, 2014 - PR Newswire - PRF
Lipocine Announces Positive Top-Line Results in Its Phase 3 Study of LPCN 1021 for Oral Testosterone Replacement Therapy 7:31 a.m. Sept. 24, 2014 - GlobeNewswire
Lipocine to Host Conference Call and Webcast to Discuss Top-Line Results From the Phase 3 Study of LPCN 1021 3:01 p.m. Sept. 23, 2014 - GlobeNewswire
Lipocine Announces First Patient Dosed in Phase 1 Study in Pregnant Women of LPCN 1107, Potentially the First Oral Product for the Prevention of Preterm Birth 3:01 p.m. Sept. 8, 2014 - GlobeNewswire
Lipocine Announces Financial and Operational Results for the Second Quarter of 2014 3:00 p.m. Aug. 13, 2014 - GlobeNewswire
Global Women%s Health Market 2014-2018 5:20 p.m. July 28, 2014 - PR Newswire - PRF
Lipocine Announces Issuance of U.S. Patent for LPCN 1021 3:00 p.m. July 15, 2014 - GlobeNewswire
Lipocine Added to Russell Microcap Index 3:46 p.m. June 30, 2014 - GlobeNewswire
Lipocine to Present at the Jefferies 2014 Global Healthcare Conference 3:16 p.m. May 29, 2014 - GlobeNewswire
Lipocine Announces First Patient Dosed in Phase 2a Study of LPCN 1111, a Novel Testosterone Ester for Oral Testosterone Replacement Therapy 3:16 p.m. May 27, 2014 - GlobeNewswire
Lipocine Announces Financial and Operational Results for the First Quarter of 2014 7:32 a.m. May 13, 2014 - GlobeNewswire
Lipocine Announces Completion of Enrollment in its SOAR Phase 3 Study for Oral Testosterone Replacement Therapy 7:02 a.m. April 29, 2014 - GlobeNewswire
Lipocine to Begin Trading on the NASDAQ Capital Market 7:44 a.m. March 18, 2014 - GlobeNewswire
Lipocine to Present at the 26th Annual ROTH Conference 8:31 a.m. March 5, 2014 - GlobeNewswire
Lipocine Announces First Patient Dosed in Phase 3 Study for Oral Testosterone Replacement Therapy 8:30 a.m. Feb. 10, 2014 - GlobeNewswire
Lipocine to Present at the 2014 Leerink Global Healthcare Conference 10:48 p.m. Feb. 4, 2014 - GlobeNewswire
Lipocine Announces New Appointments to Its Board of Directors 4:00 p.m. Jan. 7, 2014 - GlobeNewswire
MarketWatch News on LPCN
Bed Bath & Beyond surges on earnings 4:40 p.m. Sept. 23, 2014 - MarketWatch
Other News on LPCN
10-Q: LIPOCINE INC. 8:04 a.m. Nov. 10, 2014 - Edgar Online - (EDG = 10Q, 10K)
3 Pharmaceutical Stocks to Sell Now 2:45 a.m. Oct. 24, 2014 - InvestorPlace.com
Lipocine TRT candidate successful in feasibility trial 7:03 a.m. Oct. 13, 2014 - Seeking Alpha
3 Stocks Pushing The Conglomerates Sector Lower 3:33 p.m. Sept. 25, 2014 - TheStreet.com
LPCN 1021 hits primary endpoint in Phase 3 trial 9:52 a.m. Sept. 24, 2014 - Seeking Alpha
Why Lipocine (LPCN) Stock Is Surging in Morning Trading Today 8:50 a.m. Sept. 24, 2014 - TheStreet.com
FDA Advisory Committee Comments Create Buying Opportunity In Lipocine 10:39 a.m. Sept. 23, 2014 - Seeking Alpha
Rextoro gets thumbs down from Ad Comm 12:31 p.m. Sept. 18, 2014 - Seeking Alpha
Lipocine trading halted pending news 12:04 p.m. Sept. 17, 2014 - Seeking Alpha
Preview: FDA September 17 Adcom On Testosterone Replacement Therapy 7:42 a.m. Sept. 9, 2014 - Seeking Alpha
Lipocine Is A Compelling Investment Opportunity With Impending Phase 3 Data 9:20 a.m. Aug. 19, 2014 - Seeking Alpha
10-Q: LIPOCINE INC. 3:03 p.m. Aug. 13, 2014 - Edgar Online - (EDG = 10Q, 10K)
Lipocine: An Undervalued Biotech With An Approaching Catalyst 8:16 a.m. Aug. 13, 2014 - Seeking Alpha
5 Stocks With Ugly Sales Growth — HTS MITT UEC LPCN MNKD 5:00 a.m. Aug. 4, 2014 - InvestorPlace.com
Lipocine Inc. (LPCN) Surges: Stock Moves 11.6% Higher - Tale of the Tape 8:11 a.m. July 29, 2014 - Zacks.com
5 Stocks With Crummy Sales Growth — HTS MITT UEC LPCN MNKD 3:15 a.m. July 28, 2014 - InvestorPlace.com
5 Stocks With Bad Sales Growth — HTS MITT UEC LPCN MNKD 3:15 a.m. July 21, 2014 - InvestorPlace.com
5 Stocks With Poor Sales Growth — HTS MITT UEC LPCN MNKD 4:30 a.m. July 14, 2014 - InvestorPlace.com
5 Stocks With Crummy Sales Growth — HTS MITT UEC LPCN MNKD 3:15 a.m. July 7, 2014 - InvestorPlace.com
5 Stocks With Ugly Sales Growth — HTS MITT UEC LPCN MNKD 3:00 a.m. June 30, 2014 - InvestorPlace.com
Press Releases on LPCN
Lipocine Announces Management Changes 8:02 a.m. Nov. 17, 2014 - GlobeNewswire
Lipocine Announces Financial and Operational Results for the Third Quarter of 2014 8:01 a.m. Nov. 10, 2014 - GlobeNewswire
Lipocine Announces Positive Top-Line Results in Phase 2a Study of LPCN 1111 6:01 a.m. Oct. 13, 2014 - GlobeNewswire
IPOs and Transactions Week in Review: September 29 - October 3 1:25 p.m. Oct. 6, 2014 - PR Newswire - PRF
Lipocine Announces Positive Top-Line Results in Its Phase 3 Study of LPCN 1021 for Oral Testosterone Replacement Therapy 7:31 a.m. Sept. 24, 2014 - GlobeNewswire
Lipocine to Host Conference Call and Webcast to Discuss Top-Line Results From the Phase 3 Study of LPCN 1021 3:01 p.m. Sept. 23, 2014 - GlobeNewswire
Lipocine Announces First Patient Dosed in Phase 1 Study in Pregnant Women of LPCN 1107, Potentially the First Oral Product for the Prevention of Preterm Birth 3:01 p.m. Sept. 8, 2014 - GlobeNewswire
Lipocine Announces Financial and Operational Results for the Second Quarter of 2014 3:00 p.m. Aug. 13, 2014 - GlobeNewswire
Global Women%s Health Market 2014-2018 5:20 p.m. July 28, 2014 - PR Newswire - PRF
Lipocine Announces Issuance of U.S. Patent for LPCN 1021 3:00 p.m. July 15, 2014 - GlobeNewswire
Lipocine Added to Russell Microcap Index 3:46 p.m. June 30, 2014 - GlobeNewswire
Lipocine to Present at the Jefferies 2014 Global Healthcare Conference 3:16 p.m. May 29, 2014 - GlobeNewswire
Lipocine Announces First Patient Dosed in Phase 2a Study of LPCN 1111, a Novel Testosterone Ester for Oral Testosterone Replacement Therapy 3:16 p.m. May 27, 2014 - GlobeNewswire
Lipocine Announces Financial and Operational Results for the First Quarter of 2014 7:32 a.m. May 13, 2014 - GlobeNewswire
Lipocine Announces Completion of Enrollment in its SOAR Phase 3 Study for Oral Testosterone Replacement Therapy 7:02 a.m. April 29, 2014 - GlobeNewswire
Lipocine to Begin Trading on the NASDAQ Capital Market 7:44 a.m. March 18, 2014 - GlobeNewswire
Lipocine to Present at the 26th Annual ROTH Conference 8:31 a.m. March 5, 2014 - GlobeNewswire
Lipocine Announces First Patient Dosed in Phase 3 Study for Oral Testosterone Replacement Therapy 8:30 a.m. Feb. 10, 2014 - GlobeNewswire
Lipocine to Present at the 2014 Leerink Global Healthcare Conference 10:48 p.m. Feb. 4, 2014 - GlobeNewswire
Lipocine Announces New Appointments to Its Board of Directors 4:00 p.m. Jan. 7, 2014 - GlobeNewswire
(0)
(0)Scroll down for more posts ▼